Source link : https://newshealth.biz/health-news/more-data-support-trodelvy-keytruda-combo-in-triple-negative-breast-cancer/
CHICAGO — Sacituzumab govitecan (SG, Trodelvy) added to pembrolizumab (Keytruda) extended a surrogate measure of long-term clinical outcomes compared with chemotherapy plus pembrolizumab in patients with PD-L1-positive metastatic triple negative breast cancer (mTNBC), according to an analysis of the phase III ASCENT-04 trial. Median progression-free survival after the next line of treatment (PFS2) was not […]
The post More Data Support Trodelvy-Keytruda Combo in Triple-Negative Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-02 15:39:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8